1221821-48-2|(R,2E,4E,6E,8E)-((6S,7S,12R,E)-12-((2S,6R,7R,9R,E)-7,9-dihydroxy-4,6-dimethyldec-4-en-2-yl)-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl) 11-hxdroxy-4,6,8-trimethyl-13-oxopentadeca-2,4,6,8-tetraenoate

Structuredsearch

(R,2E,4E,6E,8E)-((6S,7S,12R,E)-12-((2S,6R,7R,9R,E)-7,9-dihydroxy-4,6-dimethyldec-4-en-2-yl)-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl) 11-hxdroxy-4,6,8-trimethyl-13-oxopentadeca-2,4,6,8-tetraenoate

Collect

CAS: 1221821-48-2

MF: C43H68O8

MW: 712.99522

Synonyms: (R,2E,4E,6E,8E)-((6S,7S,12R,E)-12-((2S,6R,7R,9R,E)-7,9-dihydroxy-4,6-dimethyldec-4-en-2-yl)-7,9-dimethyl-2-oxooxacyclododec-9-en-6-yl) 11-hxdroxy-4,6,8-trimethyl-13-oxopentadeca-2,4,6,8-tetraenoate

Supply Source

I can Supply this

REPORT BY

Yoshito Kishi

Harvard University

follow

Synthesis and structure assignment of the minor metabolite arising from the frog pathogen Mycobacterium liflandii

Co-reporter: Thomas Spangenberg, Sylvain Aubry, Yoshito Kishi

pp: 1782-1785

Publication Date(Web):31 March 2010

DOI: 10.1016/j.tetlet.2010.01.105